Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study
Open Access
- 19 February 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 54 (5), 1019-1024
- https://doi.org/10.1007/s00125-011-2067-y
Abstract
Lower adiponectin levels are associated with higher risk of incident type 2 diabetes. Most analyses have been adjusted for confounding factors, but few have taken into account insulin resistance per se. We tested the hypothesis that the association of adiponectin levels with incident type 2 diabetes differs between insulin-resistant and insulin-sensitive individuals. We studied two prospective cohorts: the Framingham Offspring Study (n = 2,023) and the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study (n = 887) cohorts. Insulin resistance was estimated by HOMA-insulin resistance (HOMA-IR). We used logistic regression analysis to test the association between adiponectin and incident type 2 diabetes overall and in insulin-resistant vs insulin-sensitive individuals (defined by ≥ vs <75th percentile of HOMA-IR). At baseline, Framingham’s participants were 60 ± 9 years old and 56% were women; KORA’s participants were 63 ± 5 years old and 49% were women. Type 2 diabetes incidence was 5.4% over 6.5 years (n = 109) in Framingham and 10.5% over 8 years (n = 93) in KORA. Lower adiponectin levels were associated with type 2 diabetes incidence in both cohorts. In insulin-resistant individuals, lower adiponectin levels were associated with higher risk of type 2 diabetes incidence (OR 1.60 [95% CI 1.10–2.31] per SD decrease in Framingham, p = 0.01; and OR 2.34 [95% CI 1.16–4.73] in KORA, p = 0.02); while this was not observed in insulin-sensitive individuals (OR 1.10 [95% CI 0.73–1.67] in Framingham, p = 0.64; and OR 1.34 [95%CI: 0.88–2.03] in KORA, p = 0.18). We conclude that lower adiponectin levels are associated with higher risk of type 2 diabetes in insulin-resistant but not in insulin-sensitive individuals. This suggests that some level of insulin resistance is needed to see deleterious effects of low adiponectin.Keywords
This publication has 14 references indexed in Scilit:
- Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort studyDiabetic Medicine, 2009
- Adipokines and Risk of Type 2 Diabetes in Older MenDiabetes Care, 2007
- Hypoadiponectinemia and Proinflammatory State: Two Sides of the Same Coin?Diabetes Care, 2006
- Adiponectin and the Development of Type 2 DiabetesDiabetes, 2004
- Plasma Adiponectin Is an Independent Predictor of Type 2 Diabetes in Asian IndiansDiabetes Care, 2003
- High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000Diabetologia, 2003
- Adiponectin and development of type 2 diabetes in the Pima Indian populationThe Lancet, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001
- Circulating Concentrations of the Adipocyte Protein Adiponectin Are Decreased in Parallel With Reduced Insulin Sensitivity During the Progression to Type 2 Diabetes in Rhesus MonkeysDiabetes, 2001
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985